In the fifth episode of our fourth season, our host Peter Brenders talks with Bob McLay, Vice President and General Manager of Sobi Canada, about developing and manufacturing innovative therapies for rare diseases, Canadian rare disease policy and Canada’s funding model for precision medicine.